ATE512132T1 - Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamid - Google Patents
Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamidInfo
- Publication number
- ATE512132T1 ATE512132T1 AT08719316T AT08719316T ATE512132T1 AT E512132 T1 ATE512132 T1 AT E512132T1 AT 08719316 T AT08719316 T AT 08719316T AT 08719316 T AT08719316 T AT 08719316T AT E512132 T1 ATE512132 T1 AT E512132T1
- Authority
- AT
- Austria
- Prior art keywords
- ylü
- diphenylhexanamide
- hydroxyphenoxy
- azetidine
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89516307P | 2007-03-16 | 2007-03-16 | |
PCT/IB2008/000622 WO2008135819A1 (en) | 2007-03-16 | 2008-03-06 | Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE512132T1 true ATE512132T1 (de) | 2011-06-15 |
Family
ID=39591485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08719316T ATE512132T1 (de) | 2007-03-16 | 2008-03-06 | Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamid |
Country Status (24)
Country | Link |
---|---|
US (1) | US8263583B2 (de) |
EP (1) | EP2125714B1 (de) |
JP (1) | JP4277051B2 (de) |
KR (1) | KR101120227B1 (de) |
CN (2) | CN101641327A (de) |
AR (1) | AR065714A1 (de) |
AT (1) | ATE512132T1 (de) |
AU (1) | AU2008247095B2 (de) |
BR (1) | BRPI0808413A2 (de) |
CA (1) | CA2678683C (de) |
CY (1) | CY1111701T1 (de) |
DK (1) | DK2125714T3 (de) |
ES (1) | ES2364727T3 (de) |
HK (1) | HK1189591A1 (de) |
IL (1) | IL200403A (de) |
MX (1) | MX2009009952A (de) |
NZ (1) | NZ579056A (de) |
PL (1) | PL2125714T3 (de) |
PT (1) | PT2125714E (de) |
RU (1) | RU2422439C2 (de) |
SI (1) | SI2125714T1 (de) |
TW (1) | TWI348907B (de) |
WO (1) | WO2008135819A1 (de) |
ZA (1) | ZA200906462B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ599774A (en) | 2009-11-23 | 2014-11-28 | Palatin Technologies Inc | Melanocortin-1 receptor-specific cyclic peptides |
EA201290295A1 (ru) | 2009-11-23 | 2013-01-30 | Палатин Текнолоджиз, Инк. | Специфичные к рецептору меланокортина-1 линейные пептиды |
EP2578570A1 (de) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen |
EP2641900A1 (de) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors |
EP3596046A1 (de) * | 2017-03-15 | 2020-01-22 | Mylan Laboratories Ltd. | Neuartige polymorphe von (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid-hydrochlorid |
CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
WO2020261160A1 (en) * | 2019-06-25 | 2020-12-30 | Mylan Laboratories Limited | Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
CN116033893A (zh) * | 2020-06-26 | 2023-04-28 | 迈兰制药英国有限公司 | 包含5-[3-(3-羟基苯氧基)氮杂环丁烷-1-基]-5-甲基-2,2-二苯基己酰胺的制剂 |
CN113577059B (zh) * | 2021-08-02 | 2022-05-20 | 山东大学齐鲁医院(青岛) | 一种用于小儿哮喘的活性药物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69720518T2 (de) * | 1996-12-02 | 2004-02-26 | Kyorin Pharmaceutical Co., Ltd. | Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren |
JPH11100366A (ja) | 1997-09-29 | 1999-04-13 | Kyorin Pharmaceut Co Ltd | 新規n−置換環状アミン誘導体及びその製造法 |
EP1928821B1 (de) * | 2005-09-21 | 2009-01-07 | Pfizer Limited | Carboxamid derivate als muskarin rezeptor antagonisten |
WO2008035157A1 (en) * | 2006-09-22 | 2008-03-27 | Pfizer Limited | Azetidine derivatives as muscarinic receptor antagonists |
-
2008
- 2008-03-06 ES ES08719316T patent/ES2364727T3/es active Active
- 2008-03-06 MX MX2009009952A patent/MX2009009952A/es active IP Right Grant
- 2008-03-06 BR BRPI0808413-0A patent/BRPI0808413A2/pt not_active Application Discontinuation
- 2008-03-06 KR KR1020097019239A patent/KR101120227B1/ko active IP Right Grant
- 2008-03-06 US US12/530,573 patent/US8263583B2/en active Active
- 2008-03-06 SI SI200830366T patent/SI2125714T1/sl unknown
- 2008-03-06 CA CA2678683A patent/CA2678683C/en active Active
- 2008-03-06 PT PT08719316T patent/PT2125714E/pt unknown
- 2008-03-06 CN CN200880008581A patent/CN101641327A/zh active Pending
- 2008-03-06 DK DK08719316.5T patent/DK2125714T3/da active
- 2008-03-06 WO PCT/IB2008/000622 patent/WO2008135819A1/en active Application Filing
- 2008-03-06 RU RU2009134512/04A patent/RU2422439C2/ru active
- 2008-03-06 AU AU2008247095A patent/AU2008247095B2/en active Active
- 2008-03-06 CN CN201310280277.XA patent/CN103351367B/zh active Active
- 2008-03-06 AT AT08719316T patent/ATE512132T1/de active
- 2008-03-06 PL PL08719316T patent/PL2125714T3/pl unknown
- 2008-03-06 EP EP08719316A patent/EP2125714B1/de active Active
- 2008-03-06 NZ NZ579056A patent/NZ579056A/en unknown
- 2008-03-13 AR ARP080101025A patent/AR065714A1/es not_active Application Discontinuation
- 2008-03-14 JP JP2008065066A patent/JP4277051B2/ja active Active
- 2008-03-14 TW TW097109223A patent/TWI348907B/zh active
-
2009
- 2009-08-13 IL IL200403A patent/IL200403A/en not_active IP Right Cessation
- 2009-09-16 ZA ZA200906462A patent/ZA200906462B/xx unknown
-
2011
- 2011-07-08 CY CY20111100664T patent/CY1111701T1/el unknown
-
2014
- 2014-03-18 HK HK14102704.7A patent/HK1189591A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE512132T1 (de) | Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamid | |
NO2021006I1 (no) | Quofenix, delafloksacin | |
BRPI0811280A2 (pt) | Compostos amino-heterocíclicos | |
ATE513831T1 (de) | Pyridinä3,4-büpyrazinone | |
NL2000537A1 (nl) | Aminederivaten. | |
DK3118221T3 (da) | Proteiner | |
BRPI0914772A2 (pt) | compostos heterocíclicos 1,2-dissubstituídos | |
BRPI0814466A2 (pt) | Método. | |
BRPI0810482A2 (pt) | Métodos de produção de proteína usando compostos antissenescência | |
ATE555107T1 (de) | 2-aza-bicyclo-ä2,2,1-üheptan-derivate | |
BRPI0814359A2 (pt) | Método | |
DK2046826T3 (da) | Exendin-fusionsproteiner | |
DE602007003881D1 (de) | Intraperikardiale Elektrode | |
DE502008000295D1 (de) | Nockenwelle | |
DK2126093T3 (da) | Forbedring af proteinfremstilling | |
ATE509906T1 (de) | Mandelsäurehydrazide | |
BRPI0816970A2 (pt) | 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas | |
BRPI0813144A2 (pt) | Couro | |
BRPI0814971A2 (pt) | Proteína | |
BRPI0807137A2 (pt) | Agentes antiparasitários | |
DE602007008787D1 (de) | Spannvorrichtung | |
DK2205562T3 (da) | 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater | |
DK2173831T3 (da) | Brøndbehandling | |
BRPI0809678A2 (pt) | Métodos | |
DE112007001674A5 (de) | Spannvorrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2125714 Country of ref document: EP |